AnalystsLuca IssiLuca Issi's Stock Forecasts
AnalystsLuca Issi
Sectors:
Industries:
Analyst Ranking
Bottom 2%
#4848 out of 4906 analysts
Average Return
-12.66%
Win Rate
37%46 out of 126
Risk vs Reward
Poor
Good
Luca Issi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Uniqure NvQURE | +137.93% | $5.88 | $13.99 | 2024-01-15 - 2025-01-15 | Buy |
Uniqure NvQURE | +114.25% | $7.16 | $15.34 | 2024-11-05 - 2025-06-13 | Buy |
Alnylam Pharmaceuticals IncALNY | +74.46% | $147.00 | $256.45 | 2024-02-15 - 2025-02-14 | Buy |
Alnylam Pharmaceuticals IncALNY | +67.35% | $149.69 | $250.51 | 2024-02-19 - 2025-02-19 | Buy |
Alnylam Pharmaceuticals IncALNY | +66.02% | $167.82 | $278.62 | 2023-10-10 - 2024-10-10 | Buy |
Luca Issi Analyst Color
Get additional color on Luca Issi's coverage of popular stocks
Luca Issi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Adverum Biotechnologies IncADVM | 8 | Hold | $4.00 | +62.60% | Maintains | a month ago |
Allogene Therapeutics IncALLO | 8 | Buy | $10.00 | +646.27% | Reiterates | a month ago |
Apellis Pharmaceuticals IncAPLS | 7 | Hold | $18.00 | -4.41% | Maintains | a month ago |
Moderna IncMRNA | 14 | Hold | $28.00 | +4.99% | Maintains | a month ago |
Ascendis Pharma AASND | 2 | Buy | $210.00 | +22.95% | Maintains | a month ago |
Lexeo Therapeutics IncLXEO | 5 | Buy | $20.00 | +407.61% | Maintains | 3 months ago |
Alnylam Pharmaceuticals IncALNY | 26 | Buy | $330.00 | +7.15% | Maintains | 3 months ago |
Korro Bio IncKRRO | 7 | Buy | $95.00 | +601.62% | Maintains | 3 months ago |
Sangamo Therapeutics IncSGMO | 6 | Hold | $2.00 | +307.33% | Reiterates | 3 months ago |
Ocular Therapeutix IncOCUL | 1 | Buy | $17.00 | +94.73% | Initiates Coverage On | 3 months ago |
Meiragtx Holdings PLCMGTX | 6 | Buy | $13.00 | +96.08% | Maintains | 3 months ago |
Verve Therapeutics IncVERV | 7 | Buy | $15.00 | +143.51% | Maintains | 3 months ago |
4d Molecular Therapeutics IncFDMT | 7 | Buy | $35.00 | +697.27% | Maintains | 3 months ago |
Beam Therapeutics IncBEAM | 7 | Hold | $26.00 | +52.40% | Maintains | 4 months ago |
Ionis Pharmaceuticals IncIONS | 8 | Buy | $70.00 | +96.68% | Reiterates | 4 months ago |
Biomarin Pharmaceutical IncBMRN | 12 | Hold | $70.00 | +24.51% | Reiterates | 4 months ago |
Crispr Therapeutics AgCRSP | 12 | Hold | $48.00 | +16.05% | Maintains | 4 months ago |
Arrowhead Pharmaceuticals IncARWR | 8 | Buy | $42.00 | +166.84% | Reiterates | 4 months ago |
Uniqure NvQURE | 6 | Buy | $24.00 | +56.45% | Reiterates | 5 months ago |
Schlumberger LimitedSLB | 1 | Buy | $57.00 | +57.02% | Reiterates | 5 months ago |
Regenxbio IncRGNX | 8 | Buy | $30.00 | +223.62% | Reiterates | 5 months ago |
Avidity Biosciences IncRNA | 2 | Buy | $67.00 | +113.58% | Reiterates | 5 months ago |
Dyne Therapeutics IncDYN | 2 | Buy | $45.00 | +212.28% | Reiterates | 5 months ago |
Editas Medicine IncEDIT | 8 | Hold | $4.00 | +103.05% | Maintains | 6 months ago |
Bluebird Bio IncBLUE | 4 | Hold | $80.00 | +1,509.66% | Reiterates | 7 months ago |
Ultragenyx Pharmaceutical IncRARE | 3 | Buy | $77.00 | +105.39% | Reiterates | 7 months ago |
Wave Life Sciences LtdWVE | 5 | Hold | $15.00 | +115.83% | Maintains | 8 months ago |
Intellia Therapeutics IncNTLA | 4 | Buy | $54.00 | +549.82% | Reiterates | 9 months ago |
Caribou Biosciences IncCRBU | 5 | Buy | $14.00 | +1,161.26% | Reiterates | 10 months ago |
Lenz Therapeutics IncLENZ | 3 | Hold | $3.00 | N/A | Maintains | 2 years ago |
Q32 Bio IncQTTB | 3 | Hold | $54.00 | N/A | Maintains | 3 years ago |
Dicerna Pharmaceuticals IncDRNA | 2 | Hold | $38.25 | N/A | Downgrades | 4 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.